India’s small pharma units are at a crossroads. As the country pushes to align its drug manufacturing standards with global benchmarks under the revised Schedule M, thousands of micro and small enterprises are struggling to keep up. What was intended as a quality upgrade for the sector is now...
India’s pharmaceutical industry, valued at US$ 55 billion in FY 2023-24, is rapidly emerging as a global healthcare powerhouse. With projections to reach US$ 130 billion by 2030 and an aspirational US$ 450 billion by 2047, the sector is set to nearly double its global market share to 5%. Already...
The Indian pharmaceutical industry, a global leader in high-quality, low-cost drug production, commands over 20% of global generics supply and addresses 60% of worldwide vaccine demand. Crucial to India’s economic growth and employment, the industry benefits from government initiatives like the Production Linked Incentive (PLI) scheme, which supports production, boosts...
India Business & Trade is a thought leadership initiative of the Trade Promotion Council of India, a premier trade promotion body recognised by the Department of Commerce, Government of India.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
